AMICUS THERAPEUTICS, INC. — Director's Dealing 2020

Oct 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-10-09

Reporting Person: Do Hung (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-09	Common Stock	M	43700	$8.61	Acquired	564507	Direct
2020-10-09	Common Stock	M	75000	$12.28	Acquired	639507	Direct
2020-10-09	Common Stock	M	75000	$9.03	Acquired	714507	Direct
2020-10-09	Common Stock	S	193700	$15.0298	Disposed	520807	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-09	Stock Options (right to buy)	$8.61	M	43700	Disposed	2025-01-02	Common Stock (43700)	Direct
2020-10-09	Stock Options (right to buy)	$12.28	M	75000	Disposed	2025-06-01	Common Stock (75000)	Direct
2020-10-09	Stock Options (right to buy)	$9.03	M	75000	Disposed	2026-01-04	Common Stock (75000)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.14 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: All of the options were fully vested and exercisable as of October 9, 2020.